FDA Import Refusal 799-7681633-1/12/1 — Novo Nordisk
The FDA refused shipment 799-7681633-1/12/1 from Novo Nordisk (India) on Jun 3, 2025. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jun 3, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDB72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 75